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A  feature  of the allograft reaction  is the generation  of a  subclass  of T 
lymphocytes which are capable of  lysing specifically  target cells  in vitro (1).  The 
same class  of  cytotoxic T lymphocytes may be involved in  the destruction in vivo 
of neoplastic (2) and virally infected syngeneic cells (3),  suggesting that the 
physiological function of  these cytotoxic T cells  is related to the elimination of 
antigenically abnormal cells. 
Many observations  suggest that  there is  a special  relationship  between the activity  of 
cytotoxic T  lymphocytes  and  the  serologically  determined  histocompatibility anti- 
gens. For example, when an immune reaction  occurs against murine cells  bearing a 
variety  of  foreign  or  chemically modified surface  antigens,  cytotoxic  lymphocytes are not 
generated against all of the potential  antigens,  but only against  the foreign (4, 5) or 
modified (6)  H-2 antigens.  On the other hand, cytotoxic  activity  may be undetectable in 
cultures  containing a mixture of  cells  that  are identical  at the Ho2K  and H-2D loci  but 
differ  at other loci,  despite  the presence of  a strong  proliferative  response (7, 8). 
H-2 antigens also  appear to be involved in  the T-cell-mediated  lysis  of  virally  infected 
or neoplastic  syngeneic cells  in which the H-2 antigens would not be expected to be the 
targets  of  the cytotoxic  cells.  Cytotoxic lymphocytes generated against virally  infected 
syngeneic cells  kill  virally  infected  target  cells  only  if  the  target  cells  and the  stimulating 
cells  share the  H-2K  or  H-2D  region of  the major histocompatibility  complex (MHC)  I  (9). 
Furthermore, anti-H-2 antibodies  inhibit  the lysis  of  virally  infected  (10)  or neoplastic 
cells  (11,  12) by H-2-compatible cytotoxic  T cells. 
The exact nature of  the role  of  the H-2 antigens in T-cell-mediated  lysis  is unknown. 
One key question is  whether the H-2 antigens on both the cytotoxic  lymphocyte and the 
target  cells  are important in  the lytic  event.  Although several  observations  suggest that 
the H-2 antigens on the target  cell  are important in  the lysis  of  syngeneic cells,  modified 
either  chemically (6)  or  by  viral  infection  (9),  there  is  no direct  evidence  that  H-2 antigens 
on tumor cells  are critical  for  their  lysis  by syngeneic cytotoxic  cells.  Even less  is  known 
about the possible  role of H-2 antigens on the cytotoxic  T cell,  although one recent 
observation (11)  suggests that they may not participate  in the lysis  of  syngeneic tumor 
cells. 
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In the present study, we have, therefore, investigated more closely the role of 
H-2 antigens in the killing of tumor cells by cytotoxic lymphocytes of the same 
H-2  type.  We  have  found  that  although  H-2  antigens  are  present  on  these 
cytotoxic  lymphocytes,  they  do  not  participate  in  the  lytic  event.  Our  data 
indicate, rather, that it is the H-2 antigens on the tumor cells that are crucial to 
the cytotoxic interaction. 
Materials and Methods 
Animals.  BALB/c mice were bred in our own colony and were used at 2-8 mo of age. DBA/2J, 
C57BL/6J, and F,-hybrid (C57BL/6 x  DBA/2) mice were obtained from The Jackson Laboratories 
(Bar Harbor, Maine) and were used at 2-6 mo of age. 
Antisera.  Anti-H-2  d serum was prepared by a schedule of repeated intraperitoneal injections 
of C57BL/10J mice with spleen, thymus, and lymph node cells from B10.D2/OSn mice. The anti-H- 
2 b antiserum was prepared by a similar method in which B10.D2/OSn mice were immunized with 
lymphoid cells from B10/ScSn mice. In both cases, the antisera used were prepared from the fourth 
to eighth bleedings. The Anti-Thy-l.2 serum (AKR anti-C3H) was obtained from Litton Bionetics 
(Kensington, Md.). 
Tumor Cells.  The lymphomas EL4.BU (H-2b), originally derived from a C57BL/6 mouse, and 
P386 (H-2d), originally derived from a DBA/2 mouse, were obtained from the Salk Institute. They 
were passaged in vitro and in some cases for short periods in ascitic form in vivo. 
Immunization of Mice with Tumor Cells.  BALB/c mice were immunized by the subcutaneous 
injection of 3  ×  108 untreated P368 cells. In the case of DBA/2 mice, it was necessary to use P368 
cells  which had been irradiated  with 4,000  fads  to  prevent proliferation.  C57BL/6  mice  were 
immunized with EL4 cells either by subcutaneous injection of irradiated cells or by injection in 
one hind leg with living cells, followed after 7-14 days by surgical amputation of the limb. Mice 
were used as spleen cell donors 1-2 mo after immunization. 
Tissue Culture.  Suspensions of spleen cells were prepared, and 2.5 x  107 viable nucleated cells 
were  cultured  together  with  108  tumor  cells  previously  irradiated  with  4,800  rads.  In  some 
experiments,  the  spleen  cells  were  cultured  with  107  allogeneic  spleen  cells  which  had  been 
pretreated  for 30 min at 37°C  with  mitomycin C  (40  ~g/ml).  Each  culture  contained 10  ml of 
medium in plastic flasks (No. 3012,  Falcon Plastics, Oxnard, Calif.). The medium used was RPMI- 
1640 (Associated Biomedic Systems, Buffalo, N. Y.) supplemented with glutamine (0.292 mg/ml), 
~-mercaptoethanol  (5  ×  10 -5  M),  and  fetal  calf serum  (5%)  (Associated  Biomedic  Systems). 
Cultures were incubated in humidified air with 5% CO2 for 5-6 days.  Cells from these cultures 
were termed "effector cells" and after harvest were washed and resuspended in 0.5 ml of RPMI- 
1640 medium, containing 10% fetal calf serum and HEPES (20 mM), (H-RPMI). 
Assay of Cytotoxic Activity.  A  modified ~Cr-release  assay  (13)  was used.  Assays  were  per- 
formed  in  triplicate  in  round-bottomed  microtitre  trays  (Limbro,  IS-MRC-96,  Ace  Scientific 
Supplies,  Linden,  N.  J.).  To  assay  cytotoxicity,  100  /~l  of serial  dilutions of the  effector cell 
suspension were incubated with 100 ~l of H-RPMI containing 2.5 ×  1045~Cr-labeled target cells. In 
experiments to test the effect of antisera on cytotoxicity,  50  ~l  of either H-RPMI  or  of serial 
dilutions of the antiserum under test were included in each well together with 100/~1 of H-RPMI 
containing 2.5 ×  104 51Cr.labeled target cells and 50 ~l of H-RPMI containing the cultured spleen 
cells.  Control assays in which the spleen cells were omitted were performed for each dilution of 
each antiserum, as the presence of  some mouse sera tended to reduce the spontaneous release of 
5~Cr by these target cells.  The total  counts releasable from the target cells  were determined from 
wells in which the target cells  were incubated in the presence of 1.25% NP-40. The trays were 
incubated from 1-3 h at 37°C in an atmosphere of  5% CO2 and were then stood in a water bath at 
45°C for  60 min (13).  A 0.  l-ml aliquot of  supernate was then carefully  removed from each well and 
counted in a scintillation  counter. Specific  lysis  was calculated from the formula: 
Specific  lysis =  Experimental counts released - control counts released 
total  releasable counts - control counts released 
Results are presented as the mean specific  lysis  of  triplicate  assays -+ the standard error of the 
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Treatment of Spleen Cells with Antisera and Complement.  A two-stage procedure with recon- 
stituted lyophilized guinea pig serum (Grand Island Biological Co., Grand Island, N. Y.) absorbed 
with agarose as a  source of complement was used as described elsewhere (14).  The necessary 
concentrations of anti-H-2 or anti-Thy-l.2 sera were determined in preliminary experiments. 
Results 
The  Generation  of Cytotoxic  T  Lymphocytes  Directed  against  Syngeneic  or 
Nonsyngeneic  H-2-Compatible  Tumors.  Cytotoxic lymphocytes were gener- 
ated in vitro by culturing spleen cells with syngeneic or nonsyngeneic, but H-2- 
compatible,  irradiated tumor cells (Fig.  1).  The two syngeneic combinations 
used were DBA/2 (H-2 ~) spleen cells with P388 tumor cells and C57BL/6 (H-2 b) 
spleen cells with EL4 tumor cells. The nonsyngeneic, H-2-compatible combina- 
tion was BALB/c (H-2 d)  spleen cells together with P388 (H-2 d)  tumor cells. 
Spleen cells were taken from donors that were previously immunized in vivo 
with the appropriate tumor because preliminary experiments showed that this 
resulted in higher cytotoxic activity. Cytotoxic activity was abolished when the 
cultured cells were treated with anti-Thy-l.2 serum and complement before the 
cytotoxic assay was performed (Fig.  1).  This indicated that the cytotoxic cells 
were T cells, as previously described in similar systems (1-3). 
The antigens against which these cytotoxic lymphocytes were directed have 
not been fully defined, but they cannot be simply H-2 antigens (or other products 
of the MHC) inasmuch as both the tumor and the responding population possess 
the same MHC.  In the syngeneic systems, the antigens involved in the cell- 
mediated lysis can be described as tumor-associated surface antigens (TASA). 
The  cytotoxic response,  however,  was  much  greater in  the H-2-compatible 
system than in the syngeneic systems, and therefore, many of the experiments 
were performed using cytotoxic lymphocytes generated by culturing BALB/c 
spleen cells with the P388 tumor cells.  In this case, because the BALB/c and 
DBA/2  strains differ at loci  other than the H-2  locus, it is possible that the 
BALB/c cytotoxic lymphocytes  could be directed not only against TASA on P388 
cells, but also against antigens on normal DBA lymphoid cells. In fact, we have 
observed some lysis of normal DBA spleen cells by BALB/c cells which had been 
cultured with P388 cells,  although the specific  lysis was much less than that 
observed when P388 cells were used as targets (unpublished observations). 
Presence  of H-2  Antigens  on  Cytotoxic  Lymphocytes.  A  first step  in  the 
evaluation  of the  role  of H-2  antigens  in  the  T-cell-mediated lysis  of H-2- 
compatible cells was to determine whether H-2 antigens were present on the 
surface of the cytotoxic lymphocytes. Spleen cells which had been cultured with 
irradiated H-2-compatible tumor cells were first treated with specific anti-H-2 
serum and complement and then assayed for cytotoxic activity. This pretreat- 
ment of cell populations with anti-H-2 serum and complement completely abro- 
gated cytotoxic activity (Fig.  2), indicating that H-2 antigens were present on 
the surface of these cytotoxic lymphocytes. 
H-2 Antigens on Cytotoxic Cells are not Involved in the Lysis of Allogeneic 
Target Cells.  We next investigated the question of whether the H-2 antigens 
on the cytotoxic lymphocytes are involved in the lysis of target cells.  One test of 
the  importance of these H-2  antigens in  cell lysis is  whether an  antiserum 
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FIG.  1.  Lysis of H-2-compatible tumor cells by cytotoxic T lymphocytes. BALB/c spleen 
cells were cultured for 6 days with irradiated P388 cells and assayed for cytotoxic activity 
against P388 target cells. Before assay two portions of the culture, each containing approxi- 
mately 10" BALB/c cells, were treated with either normal AKR serum ( -  •  - ) or anti-Thy- 
1.2 serum (--©--) and complement. Assay time was 150 min. 
of target  cells  of a  different H-2  type.  Several  reports  of experiments  using 
cytotoxic lymphocytes generated against allogeneic cells indicate that the pres- 
ence of anti-H-2 sera specific for the H-2 type of the cytotoxic lymphocytes does 
not  inhibit the  killing  of H-2-incompatible  allogeneic targets  (1,  7).  In  these 
studies,  however, the disparity between the number of the effector and target 
cells in the assay was not taken into account.  Because the ratio of effector to 
target cells is usually large, e.g. 100:1 (1) and 40:1 (7), it is likely that much more 
• specific anti-H-2  antibody  would be  needed to block the  H-2  antigens  on the 
effector population than  would be required to block the  H-2  antigens  on the 
target cells. For this reason, we carried out similar experiments using smaller 
ratios of effector to target cells. 
Fig.  3  shows  the  results  of such  an  experiment.  Anti-H-2 d serum  directed 
against  the  cytotoxic  lymphocytes  did  not  inhibit  lysis,  in  contrast  to  the 
inhibitory effect of the  anti-H-2 b serum  directed against  the H-2  type  of the 
target cells. When the ratio of effector cells to target cells was reduced from 10:1 
to 0.4:1, the antiserum directed against the H-2 type of the cytotoxic lymphocyte 
still did not inhibit cell-mediated lysis (Fig. 3). The reciprocal experiment using 
H-2 't target cells and a  series of dilutions of H-2 b effector cells was also carried 
out.  In this experiment, the anti-H-2  d serum blocked lysis, and even when the 
ratio of effector to target cells was less than one, the anti-H-2 b serum had no 
effect. 
The results of these experiments indicate that H-2 antigens on the cytotoxic 
lymphocytes are unlikely to play a role in the T-cell-mediated lysis of allogeneic 
cells.  Furthermore,  these  experiments suggested  that  anti-H-2  sera  inhibited 
the  lysis of tumor cells by H-2-compatible lymphocytes (11,  12)  because they 
blocked the H-2 antigens of the tumor cells. Therefore, we turned our attention 
to the effect of anti-H-2 sera on the activity of cytotoxic lymphocytes generated 
against H-2-compatible tumor cells. JOHN  W.  SCHRADER  AND  GERALD  M.  EDELMAN  605 
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FzG.  2.  H-2  antigens  are present  on the cytotoxic  T  lymphocytes  which  lyse H-2-identical 
tumor cells.  BALB/c  spleen cells were cultured with irradiated  P388  cells for 6 days,  and 
before assay  two portions  of the culture,  each  containing approximately  3  x  10  .~ BALB/c 
spleen cells,  were treated with either anti-H-2 a antiserum (--(3--)  or normal mouse serum 
(-0-)  and complement.  Assay time was 210 min. 
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FIG.  3.  The failure of antiserum  directed against the H-2 antigens  of the cytotoxic  lym- 
phocytes to inhibit cell lysis. BALB/c (H-2  d) spleen cells were cultured with mitomycin-C- 
treated  C57BL/10 (H-2  b) spleen cells for 5 days.  Cytotoxic activity was assayed using s~Cr- 
labeled EL4 cells (H-2  b) in the presence  of the indicated final dilution of anti-H-2 b serum 
(solid  circles,  -0-)  or  anti-H-2 d serum  (open  symbols,  --©--,  -.A..,  --D--).  The  cytotoxic 
activity was tested at three dilutions of the cultured BALB/c spleen cells so that the BALB/c 
cells  present  in each  well of the assay-tray  were:  2.5  ×  105 (--©--);  5  ×  104 (--A.°);  or  104 
(HE]H). The antiserum and spleen cells were maintained at 37°C for 30 min before the EL4 
cells were added.  The assays  were then incubated for 150 min. 
Target Specific anti-H-2 Sera Inhibit Lysis by Cytotoxic Lymphocytes  Gener- 
ated Against  Antigens  other  than H-2 Antigens.  First,  we  examined  whether 
the  ability  of anti-H-2  sera  to  inhibit  the  lysis  of tumor  cells  by H-2-compatible 
lymphocytes  was  correlated  with  their  specificity  for  the  H-2  antigens  on  the 
tumor  cells.  As  shown  in Table  I,  anti-H-2 d serum  inhibited  the  killing  of P388 
cells  by  cytotoxic  lymphocytes  of H-2-compatible  (BALB/c)  origin,  confirming 606  H-2  ANTIGENS  AND  TUMOR  CELL  LYSIS 
our previous observations (12).  Similarly, anti-H-2 ~ serum inhibited the lysis of 
P388 cells by syngeneic,  cytotoxic lymphocytes of DBA/2 origin  (Table I).  In 
contrast  to  anti-H-2 ~ serum,  an  anti-H-2  h serum,  produced  by  a  reciprocal 
immunization,  did not inhibit the lysis of P388 (H-2 ~) target cells (Table I). The 
same anti-H-2 b serum did, however, block cell lysis in a system in which C57BL/ 
6 (H-2 b)  spleen cells were activated against the syngeneic tumor,  EL4.  In this 
case, the anti-H-2 d antiserum had no effect. 
It  should  be  noted  that  the  H-2-compatible  BALB/c spleen  cells  produced 
about  15% specific lysis of P388 target  cells in 60 min,  whereas a  comparable 
level of lysis by the syngeneic DBA/2 spleen cells was achieved only after 180 
min (Table I). This stronger response to P388 cells by BALB/c spleen cells, as 
compared with DBA/2 spleen cells, was reproducible and was seen whether the 
spleen cells were taken from normal or immunized mice. Also shown in Table I 
are the results of an experiment in which immune BALB/c cells were stimulated 
twice in vitro  with P388 cells.  This  tertiary response resulted in 50%  specific 
lysis of P388 cells in a  60-min assay. 
To investigate further the role of the H-2 antigens in lysis by cytotoxic cells 
generated  against  antigens  other  than  H-2,  we  used  (C57BL/6  ×  DBA/2)F1 
effector cells which carried both the H-2 b and H-2 ~ haplotypes.  These effector 
cells were generated  and  assayed against  the H-2 b tumor,  EL4.  Lysis of EL4 
cells  was  not  inhibited  by  antiserum  directed  against  the  H-2 ~  haplotype, 
carried only by the effector cells, but was inhibited by antiserum against the H- 
2 ° haplotype carried by both effector and target cells (Table II). When (C57BL/6 
×  DBA/2)F1  cytotoxic lymphocytes were generated  and  assayed against  P388 
(H-2 '1)  cells,  lysis was inhibited  by the anti-H-2 d serum,  but not the anti-H-2  b 
serum. These results suggest that anti-H-2 sera inhibit tumor-specific lysis when 
they are directed against H-2 antigens present on the target cells, but not when 
directed against H-2 antigens present only on the effector-cell population. 
These experiments (Tables I and II) confirm that H-2 sera block the lysis of tu- 
mor cells by H-2-compatible cytotoxic lymphocytes. Furthermore,  they support 
the conclusion that the sera are blocking because of their anti-H-2 activity. The 
anti-H-2 b serum inhibited the lysis of H-2 ~ tumor cells but not the lysis of H-2 '1 
cells, and reciprocally, the anti-H-2 d serum inhibited the lysis of H-2 ~ cells but 
not H-2 ~ cells. In addition, the experiments described suggest that while the H-2 
antigens on cytotoxic lymphocytes are not important in lysis (Fig. 3, Table II), 
the H-2 antigens on the tumor cells are. 
The Effect of Pretreatment  of the Target  Cells  with anti-H-2  Serum.  To test 
this hypothesis,  H-2 antigens  on target  cells were blocked by treatment  with 
anti-H-2 serum before exposure to the cytotoxic lymphocytes. During labeling 
with  '~'lCr, P388  cells  were  incubated  with  anti-H-2 d serum  and  washed.  To 
insure maximal masking of H-2 antigens (15), the cells were then incubated for 
an additional 30 min with rabbit antibodies against mouse Ig and washed. These 
pretreated  target  cells  were partially  protected from lysis by H-2-compatible 
cytotoxic lymphocytes (Fig.  4). 
The incompleteness of the inhibition could not be accounted for bY the disso- 
ciation  of antibody  from  the  P388  cells,  because  staining  with  fluorescein- JOHN  W.  SCHRADER  AND  GERALD  M.  EDELMAN  607 
TABLE  I 
Specificity of the Inhibition  by Anti-H-2 Sera of the Killing ofP388 Cells by H-2- 
Identical or Syngeneic Cytotoxic Lymphocytes 
Final dilu-  Specific lysis 
Cytotoxic  Assay  tion of 
cells  time  mouse se-  No mouse 
NMS  Anti-H-2  d  Anti-H-2  b 
rum  serum 
rain  %  %  %  % 
BALB/c*  60  1/16  -  13  ±  1.4  18  ±  1.3  14  ±  0.6 
1/8  -  16  ±  1.5  13  ±  2.0  18  ±  0.7 
1/4  -  16  ±  0.7  7  -+  1.1~  16 ±  0.7* 
BALB/c*  70  -  19  ±  2.0  -  -  - 
1/8  -  -  20  _+  2.5  21  ±  1.0 
1/4  -  -  10.6  -+  1.5§  25 ±  3.5§ 
DBA/2*  180 
BALB/c¶  60 
1/16 
1/8 
1/4 
-  51  ±  1.3 
1/16 
1/8 
1/4 
16  ±  0.3  18  ±  0.7 
17  _+  0.1  18  ±  3.0 
9  ---  1.0[I  17 ±  1.Oil 
_  m 
47  -+  4.5  50  ±  4.0 
50  ±  1.2  53  -  1.2 
33  -+  5.5**  50 -  4.5** 
Comparable results were obtained in eight similar experiments. 
* Spleen cells from immunized mice were cultured with irradiated P388 cells for 5 days. 
P  <  0.005. 
II e  <  0.005. 
§ 0.01  <  P  <  0.025. 
¶  Spleen cells from immunized BALB/c mice were cultured for 7 days with irradiated P388 cells. 
Another 106 irradiated P388 cells were then added and the cultures were assayed after a further 5 
days. 
** 0.025  <  P  <  0.05. 
TABLE  II 
b  d  The Effect of  Anti-H-2  and Anti-H-2  Sera on the Cell-Mediated 
Lysis of EL4 Cells by (C57BL/6  x  DBA/2)F1 Lymphocytes 
Specific lysis 
Dilution of antisera 
Anti-H-2  d  Anti-H-T  ~ 
% 
1/16  49  _  3.4  42  -+  2.2 
1/8  56  _+  2.3  39  ±  7.4 
1/4  46  ±  11.0"  22  -  1.6' 
Spleen cells from  (C57BL/6  x  DBA/2)F~  mice,  previously immunized 
with irradiated EL4 cells, were cultured for 6 days with irradiated EL4 
cells. Cytotoxic activity against EL4 cells was measured in a 3 h assay in 
the presence of the indicated dilutions of either the anti-H-2  d or anti-H- 
2 b serum. 
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conjugated antibodies against rabbit-Ig indicated that bright caps persisted for 
at  least  4.5  h.  The  difficulty  of completely  inhibiting  cell-mediated  lysis by 
capping of specific antigens  has been reported previously (16) and probably is 
due to the thermodynamic properties of the T-cell-target  cell interaction  (17). 
Nevertheless,  this  experiment  indicates  that  a  procedure that blocks the  H-2 
antigens on the tumor cell alone can inhibit lysis by H-2-compatible cytotoxic 
cells. 
The Blocking of Cytotoxicity  by anti-H-2 Serum Directed Against  the Target 
Cell Alone.  We have  observed that  cytotoxic lymphocytes generated  against 
H-2-compatible tumor cells are able to lyse H-2-incompatible tumor cells. This 
finding allowed us to test the effects of anti-H-2 sera directed only against the 
target cell.  When BALB/c (H-2 d)  spleen cells from normal mice were cultured 
together with H-2 d P388 cells, cytotoxic cells were generated which were able to 
lyse the H-2 b lymphoma, EL4 (Table III). Lysis was inhibited (Table III) by anti- 
H-2  b serum, which was directed against H-2 antigens present only on the target 
cells.  The  anti-H-2 b serum  was raised  in H-2 d (B10.D2)  mice  and,  therefore, 
should  not  bind  to  the  H-2  d antigens  of the  BALB/c cytotoxic lymphocytes. 
Similar concentrations of anti-H-2 d antiserum had no effect in this system. This 
experiment indicates that  antiserum directed towards the H-2 antigens  of the 
tumor cell alone inhibits lysis by cytotoxic lymphocytes which have been gener- 
ated against antigens on H-2-compatible cells. 
Discussion 
The  demonstration  that  specific  anti-H-2  sera  inhibit  the  lysis  of virally 
infected (10) or neoplastic (11,  12) cells by syngeneic or H-2  identical cytotoxic 
lymphocytes provides direct evidence for a special role for the H-2 antigens (or a 
closely-linked product of the MHC) in immune surveillance.  The major conclu- 
sion that can be drawn from the present experiments is that the H-2 antigens on 
the target cell, but not those on the cytotoxic lymphocyte, are critical in the lysis 
of tumor cells by H-2-compatible T cells. 
Our results showed that H-2 antigens were present on the cytot0xic lympho- 
cytes active against H-2-compatible tumor cells (Fig.  2).  Two types of experi- 
ment,  however,  indicated  that  the  H-2  antigens  on  cytotoxic cells  were  not 
involved in the lysis of target cells. First, cytotoxic lymphocytes were generated 
and assayed against allogeneic target cells. Antiserum specific for the H-2 type 
of the cytotoxic lymphocytes failed to block cytotoxicity even when very small 
numbers of cells of this H-2  type were present (see Fig. 3). Furthermore,  these 
same antisera  were able to block cytotoxicity in reciprocal experiments  when 
they were directed against the H-2 type of the target cell. Second, the lysis of(H- 
2 b)  EL4 cells by (C57BL/6  ×  DBA/2)F1 lymphocytes, which carry both the H-2 b 
and H-2 d haplotypes, was not inhibited by anti-H-2 d serum, but was inhibited by 
anti-H-2 b serum (Table II). The same anti-H-2 d serum could, however, block the 
lysis  of H-2 d  target  cells  (Table  I,  Fig.  4).  Similarly,  it  has  been  observed 
recently that neither an anti-H-2K k or an anti-H-2D k antiserum  inhibited the 
lysis of H-2 d tumor cells by cytotoxic lymphocytes from F1 hybrids carrying the 
H-2 k and H-2 ~ haplotypes (11). 
The results of these two types of studies suggest that it is unlikely that H-2 JOHN  W.  SCHRADER  AND  GERALD  M.  EDELMAN  609 
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FIG.  4.  Coating tumor cells with anti-H-2 antibody inhibits their lysis by H-2-identical 
cytotoxic lymphocytes. P388 cells (2.5  x  l0  s) were incubated for 30 rain at 37°C with either 
anti-H-2  d serum (100 ~l) or medium alone together with Na-(51Cr) chromate (50 ~C). After 
washing, the P388  cells were incubated for an additional 30  rain at 37°C with a  gamma 
globulin fraction (200 ~g) of a  rabbit antiserum against mouse Ig. These P388  cells were 
then used as targets for cytotoxic BALB/c cells which had been generated against irradiated 
P388 cells. Lysis obtained using the P388 cells treated with anti-H-2  d serum is shown by the 
open circles (°-O--); lysis obtained using as targets the P388 cells treated with medium alone 
is shown by the closed circles (-0-). 
TABLE  III 
Inhibition  of Cell-Mediated Lysis by Serum Directed Against H-2 
Antigens  Only on the Tumor Cell 
Dilution of mouse se- 
rum 
Specific lysis 
No serum  Anti-H-2  b  NMS 
-  22  -+ 0.4  -  - 
1/8  -  12  _+  1.5  18  _+  4.0 
1/4  -  0  23  _+  0.5 
BALB/c (H-2 d) spleen cells were cultured with the H-2 d tumor P388 and were 
assayed against the H-2 b tumor EL4. Assays were performed in medium alone 
or in the presence of either anti-H-2  b serum or normal mouse serum. Assay 
time was 150 min. 
antigens function either as a part of the T-cell receptor or through binding by 
complementarity to H-2 antigens on the target cells.  Furthermore, they imply 
that anti-H-2 sera inhibit the lysis of syngeneic tumor cells by blocking H-2 
antigens on these cells.  Two lines of evidence support this contention. First, 
coating of the H-2 antigens on the target cell by pretreatment of the target cells 
with anti-H-2 serum followed  by rabbit antibodies against mouse Ig,  clearly 
reduced lysis of tumor cells by H-2-compatible cytotoxic lymphocytes (Fig.  4). 
Second, when cytotoxic lymphocytes generated against H-2-compatible tumor 
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was inhibited by anti-H-2 sera that could bind only to the target cell (Table III). 
It seems unlikely that the binding of anti-H-2 sera to target cells blocks lysis for 
nonspecific reasons. For example, there is evidence that the presence of anti-H-2 
serum directed against specificities carried by only some of the H-2 molecules on 
a  target cell does not prevent lysis of the target cell by cytotoxic lymphocytes 
directed against other H-2 specificities carried by the target cell (1, 7). We con- 
clude, therefore, that the H-2 antigens of tumor cells play a crucial role in lysis 
by H-2-compatible cytotoxic lymphocytes. 
The fact that  the anti-H-2  sera used inhibit the lysis of tumors of only the 
corresponding H-2 type (Tables I and II) suggests that this inhibition is not due 
to  the  antiviral  antibodies  which  are  found  in  most  alloantisera  (18),  (R.  J. 
Milner  and  G.  M.  Edelman,  unpublished  observations).  Such antibodies may 
possibly be provoked by the  production  of virus,  which  has been reported  to 
occur in allograft reactions (10). 
Some critical  experimental  details related to the inhibition  of cell-mediated 
cytotoxicity of antisera  in this  system are  worthy of mention.  The  sigmoidal 
character  of the plot of the extent of lysis against the number of effector cells 
added (e.g.,  Fig.  2) means that  at very high levels of lysis, inhibition  may be 
inherently difficult to detect.  Moreover, longer incubation times were found to 
be associated with reduced degrees of inhibition,  even when the concentrations 
of spleen  cells  were  reduced  to  give  comparable  final  levels  of lysis.  This 
increasing  resistance  of cell-mediated  cytotoxicity  to  inhibition  by  anti-H-2 
serum with longer incubation times has been described in an allogeneic system 
(20) and was predicted on thermodynamic grounds (17).  Optimal conditions for 
the demonstration of inhibition by antiserum therefore involve short incubation 
periods and a  more moderate degree of lysis (15-50%).  The presence of effector 
cell populations with high cytotoxic activity allows the use of short incubation 
times and lower numbers of effector spleen cells, the latter being important in 
reducing competition with the target cells for the anti-H-2 antibody. 
It was striking that there was a larger cytotoxic response against the DBA/2 
tumor P388 by BALB/c spleen cells than by DBA/2 spleen cells (Table I).  The 
mixed  lymphocyte reaction  generated  by cells  differing  at  the  M  locus  (21), 
which is among the non-H-2 loci at which BALB/c and DBA/2 mice differ, has 
been  reported  to  enhance  the  production  of cytotoxic  lymphocytes  directed 
against  H-2 antigens  on third party cells (22).  The present observation, there- 
fore,  may represent  an example of a  similar  enhancement  of a  response to a 
tumor-associated antigen  on H-2-identical cells. 
Previous studies indicate that T-cell-mediated lysis is restricted to target cells 
sharing private H-2 specificities with the stimulating cells (9, 23). The killing of 
EL4 cells (H-2 ~) by BALB/c cytotoxic lymphocytes which have been activated 
against  P388  cells (H-2d),  (Table  III),  appears  to  contradict  this  hypothesis. 
Moreover, we and others (6) have found that  cytotoxic lymphocytes generated 
against chemically-modified syngeneic spleen cells will kill chemically-modified 
tumor cells which differ at the H-2 locus. The fact that the lysis of EL4 cells by 
BALB/c cytotoxic cells was inhibited by anti-H-2 b serum (Table III) suggests, 
however,  that  the  cytotoxic lymphocyte must  recognize  H-2  antigens  on  the 
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with the stimulating cells. Other data suggest that some cytotoxic lymphocytes 
recognize regions of the H-2 molecule other than those determining the private 
specificities (7). Furthermore, cross-reactions between modified H-2 antigens of 
different private specificities might be expected because such antigens share at 
least some chemical similarities (24). 
H-2  molecules on  the  target  cell could participate  in  the cytotoxic events 
described here in at least two ways: they could be involved in determining the 
nature of the target antigen recognized by a  single receptor on the cytotoxic T 
cell or they could be the target of a  second set of T-cell receptors which are 
specific for H-2 antigens. Dual recognition of tumor-associated antigens and H-2 
antigens by two separate receptor systems on the T  cell seems unlikely for a 
variety of reasons (6, 9, 23). The first hypothesis is, therefore, more attractive, 
but requires an explanation  of how H-2  molecules affect the specificity of a 
single target antigen recognized by the cytotoxic T cell. 
One explanation may be that the MHC specifies a glycosyl transferase which 
modifies other cell surface components in a  manner characteristic of each H-2 
haplotype (25). However, because anti-H-2 sera precipitate only one major cell 
surface component (26) and the carbohydrate moieties of H-2 antigens do not 
contribute to their serological specificity (discussed in ref.  15, p.  372),  experi- 
ments demonstrating that anti-H-2 antisera inhibit the lysis of target cells by H- 
2-compatible cytotoxic lymphocytes (10-12,  and the present data) suggest that 
the H-2 antigens are more directly involved in the lytic event. Another possibil- 
ity is that the H-2 antigens themselves are antigenically altered as a  result of 
viral infection (6, 27). 
One possible mechanism is that both H-2 and, for example, tumor viral anti- 
gens contribute specificity to a  hybrid antigenic determinant (27,  23,  12). We 
have recently found that H-2 and viral antigens on tumor cells can be cocapped 
and copatched, suggesting that these antigens can become physically associated 
on the cell surface (12). The observation that both antiviral (28) and anti-H-2 
sera (10) can block lysis of virally-infected cells is consistent with the view that 
the T-cell receptor binds to such a physical complex of viral and H-2 antigens. 
Furthermore, cytotoxic lymphocytes are specific for particular viral or tumor- 
associated antigens (29, 30), suggesting that the target for cytotoxic lymphocytes 
cannot result from perturbations of the H-2 molecule that are independent of the 
nature of those antigens.  A  complex of H-2 and viral  antigens would form a 
hybrid antigen in which the determinants of the junction region would have 
elements of both the self (H-2) and viral components. The receptor repertoire of 
the population of cytotoxic T-cell precursors (31) would then be directed against 
such hybrid antigens formed from H-2 antigens and viral or other foreign cell 
surface antigens. 
Finally, it may be of value to consider the relevance of the present findings 
and those of other workers to the possible functions of H-2 antigens. First, H-2 
antigens may serve as a  substrate for the production of a  new antigenic de- 
terminant (27, 6, 12). The polymorphism of H-2 antigens could provide a variety 
of new antigens and thus increase potential immunogenicity (32,  6,  33).  Sec- 
ond, H-2 molecules may associate in some way with foreign cell surface antigens 
(12), and the mechanism for the association may involve the polymorphism of 612  H-2  ANTIGENS AND  TUMOR CELL LYSIS 
H-2 antigens (e.g., 33). Third, the H-2 molecule may be a specialized participant 
in the lytic event (23,  5).  Such a  function could reflect a  structural  and evolu- 
tionary relationship with complement components. 
Summary 
Cytotoxic T  lymphocytes were generated in vitro against H-2-compatible or 
syngeneic tumor cells.  In vitro cytotoxic activity was inhibited by specific anti- 
H-2 sera, suggesting that H-2 antigens are involved in cell lysis. Two observa- 
tions directly demonstrated the participation of the H-2 antigens on the tumor 
cells in their lysis by H-2-compatible T  cells.  First, coating of the H-2 antigens 
on  the  target  tumor  cell  reduced  the  number  of cells  lysed  on  subsequent 
exposure  to  cytotoxic T  cells.  Second,  when  cytotoxic T  cells  were  activated 
against  an  H-2-compatible  tumor  and  assayed  against  an  H-2-incompatible 
tumor, anti-H-2 serum that could bind to the target cell, but not to the cytotoxic 
lymphocyte, inhibited lysis. 
H-2  antigens  were also  shown  to be present  on the  cytotoxic lymphocytes. 
Specific antisera  reacting with these H-2 antigens,  but not those of the target 
cell, failed to inhibit lysis when small  numbers  of effector cells were assayed 
against H-2-incompatible target cells or when effector cells of Fl-hybrid origin 
and bearing two H-2 haplotypes were assayed against a tumor cell of one of the 
parental strains.  These findings suggest that it is the H-2 antigens on the tumor 
cell  and  not  those  on  the  cytotoxic lymphocytes that  are  important  in  cell- 
mediated lysis of H-2-compatible  tumor cells. 
We are grateful to Ms. M. Huber and Ms. B. Rubin for their excellent technical assistance. 
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